Acute pyelonephritis
Therapeutic area
Nephrology
Rare disease
No
- Definition
- Sudden onset pyelonephritis.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Acute pyelonephritis
- Therapeutic area
- Nephrology
- acute pyelonephritis
- pyelonephritis, acute
- Severity
- Severe
- Acquired
- Inflammatory
- Infectious Disease
- Nephrology
- Reproductive Health
- MONDO ID
- MONDO:0003529
- Parent condition
- MONDO:0006939
Related records
Broader conditions (22)
- Acute disease
- Bacterial infectious disease
- Bacterial urinary tract infection
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Female reproductive system disorder
- Human disease
- Infectious disease
- Inflammatory disease
- Kidney disorder
- Nephritis
- Pyelitis
- Pyelonephritis
- Renal infectious disease
- Reproductive system disorder
- Urinary system disorder
- Urinary tract infection
Trials (39)
- 3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children
- A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
- A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)
- A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
- Accuracy of Infection Biomarkers in the Investigation of Patients With Suspected Acute Pyelonephritis
- Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
- Clinical Characteristics of Acutely Hospitalized Adults With Acute Pyelonephritis
- CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria
- Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection
- Diagnostic Imaging of Acute Pyelonephritis
- Duration of Antibiotic Therapy in Acute Kidney Graft Pyelonephritis (AGPN): Effect on the Risk of Recurrence
- Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
- Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
- Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
- Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.
- Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children
- Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
- Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
- Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections
Other linked drugs (1)
- Benapenem